BDBM50144331 4-Azepan-4-yl-2-(1H-imidazol-4-yl)-butyric acid::CHEMBL306663
SMILES: OC(=O)C(CCC1CCCNCC1)c1cnc[nH]1
InChI Key: InChIKey=GAIGLPJJMSVFPK-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carboxypeptidase B2 isoform A (Homo sapiens (Human)) | BDBM50144331 (4-Azepan-4-yl-2-(1H-imidazol-4-yl)-butyric acid | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibitory potency against human TAFIa (thrombin-activatable fibrinolysis inhibitor) | Bioorg Med Chem Lett 14: 2141-5 (2004) Article DOI: 10.1016/j.bmcl.2004.02.033 BindingDB Entry DOI: 10.7270/Q2N8797S | |||||||||||
More data for this Ligand-Target Pair |